Exchange: NYSEMkt·Updated 06:15 PM EDT
ATNM logo

ATNM Actinium Pharmaceuticals Inc

$1.10
$0.03
(2.86%)
Today
Closed $1.08
$0.0165
(1.53%)
After Hours
Reported EarningsJul 28
Mkt Cap$33.01M
Vol159,003.00

About ATNM

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, discovery, and clinical development of targeted radiotherapies. It also develops and markets medicines for relapsed and refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
46

Neutral Sentiment

How do you feel about ATNM?

Advertisement|Remove ads.